Synergistic Integration of Phenobarbital Sodium with AI, IoT, Blockchain, and Novel Materials for Enhanced Stability and Authenticity
Legal Citation
Summary of the Inventive Concept
The present inventive concept integrates the patented lyophilized pharmaceutical composition of phenobarbital sodium with advanced technologies such as AI, IoT, blockchain, and novel materials to create a more powerful system for ensuring stability, authenticity, and real-time tracking of pharmaceutical compositions during storage and distribution.
Background and Problem Solved
The original patent addressed the stabilization of phenobarbital sodium for injection by controlling ethanol content. However, this solution had limitations in terms of real-time tracking, supply chain management, and material stability. The present inventive concept solves these problems by integrating distinct technologies to create a comprehensive system.
Detailed Description of the Inventive Concept
The new system comprises a lyophilized pharmaceutical composition of phenobarbital sodium integrated with an AI-powered monitoring device for real-time tracking of total impurities during storage. The system also utilizes IoT sensors to monitor the composition and machine learning algorithms to predict shelf-life. Additionally, a blockchain-based supply chain management system ensures authenticity and integrity of the compositions. Furthermore, a novel material composition with a porous matrix enhances stability and reduces impurities during storage. A smart packaging system with sensor-enabled containers detects and alerts for any changes in the composition's stability during storage.
Novelty and Inventive Step
The new claims introduce novel and non-obvious combinations of technologies that provide a synergistic effect, enhancing the stability, authenticity, and real-time tracking of pharmaceutical compositions. The integration of AI, IoT, blockchain, and novel materials with the patented lyophilized pharmaceutical composition of phenobarbital sodium constitutes a new and inventive step.
Alternative Embodiments and Variations
Alternative embodiments may include integrating the inventive concept with other pharmaceutical compounds or using different AI algorithms for real-time tracking. Variations may include modifying the novel material composition or using alternative blockchain platforms for supply chain management.
Potential Commercial Applications and Market
The present inventive concept has significant commercial potential in the pharmaceutical industry, particularly in the areas of neonatal seizure treatment and supply chain management. The system's ability to ensure authenticity, stability, and real-time tracking of pharmaceutical compositions makes it an attractive solution for pharmaceutical companies, hospitals, and healthcare providers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/19 |
| A | A61 | A61K9/08 |
| A | A61 | A61K31/515 |
| A | A61 | A61K47/10 |
| A | A61 | A61P25/08 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical formulation and drug delivery systems, with specialized expertise in lyophilized pharmaceutical compositions, stability analysis, and advanced monitoring technologies for pharmaceutical products
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in pharmaceutical sciences, chemical engineering, or related fields, possessing knowledge of drug formulation techniques, stability testing, sensor technologies, and emerging pharmaceutical tracking methods
Obviousness Rationale
A PHOSITA would recognize that integrating modern monitoring and tracking technologies with existing pharmaceutical formulation techniques represents a predictable extension of known technological approaches. The proposed AI, IoT, and blockchain systems provide logical enhancements to pharmaceutical stability and supply chain management that would be apparent to someone skilled in pharmaceutical technology and digital tracking systems. The variations represent incremental improvements that leverage existing technological capabilities to address known challenges in pharmaceutical composition monitoring and preservation.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,683 |
|---|---|
| Title | Stabilization of phenobarbital sodium for injection |
| Assignee(s) | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED |